It also addresses multiple Alzheimer’s disease mechanisms, reducing β-amyloid aggregation, inhibiting tau hyperphosphorylation, and alleviating oxidative stress, neuroinflammation, and apoptosis (Liang and Wang, 2022). Here, MAPT is linked to early-onset autosomal dominant Alzheimer disease.